SMTL ID : 6ggh.2 (1 other biounit)

Human jak1 kinase domain in complex with inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.70 Å

Oligo State

monomer

Ligands

1 x EYQ: ~{N}-[5-methyl-4-[7-[[(2~{R})-2-(4-methylpiperazin-1-yl)propanoyl]amino]-1~{H}-indol-3-yl]pyrimidin-2-yl]cyclopropanecarboxamide(Non-covalent)

EYQ.1: 20 residues within 4Å: Chain A: R.17, L.19, G.20, V.27, A.44, K.46, M.94, E.95, F.96, L.97, P.98, G.100, E.104, D.141, R.145, N.146, L.148, G.158, D.159, D.180 20 PLIP interactions: 20 interactions with chain A Hydrophobic interactions: A:L.19, A:L.19, A:V.27, A:A.44, A:F.96, A:F.96, A:L.148 Hydrogen bonds: A:L.97, A:L.97, A:R.145, A:D.159, A:D.159 Water bridges: A:S.101, A:S.101, A:N.146 Salt bridges: A:D.141, A:D.141, A:D.159, A:D.180, A:D.180

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Nilsson, M., Inhibition of local lung inflammation by a potent and selective JAK1 inhibitor; activation of JAK1, but not JAK3, is critical to IL-4R mediated immune cell signalling. To Be Published

Release Date

2019-05-22

Peptides

Tyrosine-protein kinase JAK1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Tyrosine-protein kinase JAK1

Related Entries With Identical Sequence